Published in Virol J on March 14, 2017
Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci U S A (1993) 22.33
Trans-activator gene of human T-lymphotropic virus type III (HTLV-III). Science (1985) 12.75
Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. J Virol (1998) 10.94
Genetic variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients. Cell (1986) 9.01
Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120. J Virol (2000) 6.71
Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction. Biotechnol Annu Rev (2005) 4.72
HIV-1 Tat assembles a multifunctional transcription elongation complex and stably associates with the 7SK snRNP. Mol Cell (2010) 3.49
Origins of HIV and the AIDS pandemic. Cold Spring Harb Perspect Med (2011) 2.98
Rapid production of retroviruses for efficient gene delivery to mammalian cells using 293T cell-based systems. Curr Protoc Immunol (2001) 2.90
Silencing and variegation of gammaretrovirus and lentivirus vectors. Hum Gene Ther (2005) 2.81
Gaussia luciferase reporter assay for monitoring biological processes in culture and in vivo. Nat Protoc (2009) 2.27
The sensitivity and specificity of the MTS tetrazolium assay for detecting the in vitro cytotoxicity of 20 chemicals using human cell lines. Toxicology (1997) 2.21
Crystal structure of HIV-1 Tat complexed with human P-TEFb. Nature (2010) 2.08
Tat is required for efficient HIV-1 reverse transcription. EMBO J (1997) 1.90
Genetic divergence of human immunodeficiency virus type 1 Ethiopian clade C reverse transcriptase (RT) and rapid development of resistance against nonnucleoside inhibitors of RT. Antimicrob Agents Chemother (2002) 1.82
Human Polymerase-Associated Factor complex (PAFc) connects the Super Elongation Complex (SEC) to RNA polymerase II on chromatin. Proc Natl Acad Sci U S A (2011) 1.56
Update on HIV-1 diversity in Africa: a decade in review. AIDS Rev (2012) 1.44
Self-inactivating gammaretroviral vectors for gene therapy of X-linked severe combined immunodeficiency. Mol Ther (2008) 1.44
Functions of Tat: the versatile protein of human immunodeficiency virus type 1. J Gen Virol (2009) 1.29
In vitro nuclear interactome of the HIV-1 Tat protein. Retrovirology (2009) 1.13
Does genetic diversity of HIV-1 non-B subtypes differentially impact disease progression in treatment-naive HIV-1-infected individuals? A systematic review of evidence: 1996-2010. J Acquir Immune Defic Syndr (2012) 1.06
Regulation of human immunodeficiency virus type 1 gene expression by clade-specific Tat proteins. J Virol (2005) 1.03
Potent inhibition of HIV-1 replication by a Tat mutant. PLoS One (2009) 1.00
Tat HIV-1 primary and tertiary structures critical to immune response against non-homologous variants. J Biol Chem (2002) 1.00
A review of HIV-1 Tat protein biological effects. Cell Biochem Funct (2005) 0.95
Tits and bits of HIV Tat protein. Expert Opin Biol Ther (2011) 0.93
Tat, Tat-associated kinase, and transcription. J Biomed Sci (1998) 0.88
Nullbasic, a potent anti-HIV tat mutant, induces CRM1-dependent disruption of HIV rev trafficking. PLoS One (2012) 0.86
The HIV-1 Tat protein stimulates reverse transcription in vitro. Curr HIV Res (2007) 0.86
Do HIV-1 non-B subtypes differentially impact resistance mutations and clinical disease progression in treated populations? Evidence from a systematic review. J Int AIDS Soc (2014) 0.84
Gene target specificity of the Super Elongation Complex (SEC) family: how HIV-1 Tat employs selected SEC members to activate viral transcription. Nucleic Acids Res (2015) 0.83
A mutant Tat protein provides strong protection from HIV-1 infection in human CD4+ T cells. Hum Gene Ther (2013) 0.82
A HIV-1 Tat mutant protein disrupts HIV-1 Rev function by targeting the DEAD-box RNA helicase DDX1. Retrovirology (2014) 0.81
Making a Short Story Long: Regulation of P-TEFb and HIV-1 Transcriptional Elongation in CD4+ T Lymphocytes and Macrophages. Biology (Basel) (2012) 0.80
Human immunodeficiency virus-1 (HIV-1)-mediated apoptosis: new therapeutic targets. Viruses (2014) 0.79
A mutant tat protein inhibits HIV-1 reverse transcription by targeting the reverse transcription complex. J Virol (2015) 0.79
Enrichment of HIV-1 subtype AD recombinants in a Ugandan cohort of severely septic patients. PLoS One (2012) 0.78
Construction of a high titer infectious HIV-1 subtype C proviral clone from South Africa. Viruses (2012) 0.77
HIV pathogenesis: mechanisms of susceptibility and disease progression. Curr Opin Microbiol (1998) 0.77
Shutdown of HIV-1 Transcription in T Cells by Nullbasic, a Mutant Tat Protein. MBio (2016) 0.76